“Overview of Available Treatment and New Drug Action Points in Obesity Pharmacology. Will GIP, Glucagon, Amylin Replace GLP-1?”. 2025. Prospects in Pharmaceutical Sciences 23 (2): 42-49. https://doi.org/10.56782/pps.361.